Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Global Hospital Acquired Infections Therapeutic Databank Market Report
... 2.02% from 2023 to 2031. Antibacterial Drugs segment is expected to be the highest contributor to this market, with $9,937.3 Million in 2022, and is anticipated to reach $11,555.8 Million by 2031, registering a CAGR ... Read More
-
Global Zika Virus Testing Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika ... Read More
-
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Medical Microbiology Testing Technologies Market (Indication: Respiratory Diseases, Neurological Diseases, Infectious Diseases, and Others; and Technology: Cell Culture, Microscopy, and Serology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Technologies Market – Scope of Report TMR’s report on the global medical microbiology testing technologies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Viral Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenoviral Vectors, Aden-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Application (Gene Therapy, Vaccinology), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Viral Vector Manufacturing market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Specialty Injectable Generics Market Size, Trends, Analysis, and Outlook By Type (Drugs, Biologics), By Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Generics market size is poised to register 8.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Specialty Injectable Generics market across By ... Read More
-
RNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032
... End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032 The global RNA Therapeutics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Cell and Gene Therapy Manufacturing Services Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Indication (Oncology, Cardiovascular, Orthopedic, Ophthalmology, Central Nervous System, Infectious Diseases, Others), By Application (Clinical Manufacturing, Commercial Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Cell and Gene Therapy Manufacturing Services market size is poised to register 22.3% growth from ... Read More
-
Vaccine Adjuvants Market Size, Trends, Analysis, and Outlook By Product (Adjuvant Emulsions, Pathogen Components, Saponin-based adjuvants, Particulate Adjuvants, Others), By Route of Administration (Intramuscular, Subcutaneous, Others), By Disease (Infectious Diseases, Cancer, Others), By Application (Research Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032
... Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032 The global Vaccine Adjuvants market size is poised to register 13.7% growth from 2024 to 2032, presenting significant ... Read More
-
Infectious Disease Drugs Market Size, Trends, Analysis, and Outlook By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Drugs market across By Disease (HIV, ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Viral Vectors, Plasmid DNA), By Products and Services (Product, Services), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Cell and Gene Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Viral Vector and Plasmid ... Read More
-
Targeted Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product Type (Kits/Panels and Assays, Instruments and Other), By Target Enrichment Method (Amplicon Sequencing, Hybridization Capture, and Others), By Target Capture Type (Targeted DNA Sequencing ,Targeted RNA Sequencing and others), By Application(Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, and Others), By End Users (Academic and Research Institution, Pharmaceutical and Biotech Companies, Diagnostic & Clinical Laboratories and Other), By Region, By Competition, 2019-2029F
... Capture Type (Targeted DNA Sequencing ,Targeted RNA Sequencing and others), By Application(Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, and Others), By End Users (Academic and Research Institution, Pharmaceutical and ... Read More
-
Point of Care Infectious Disease Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology
... and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
-
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
... market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 172.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9.4% during 2024-2032. The rising number of ... Read More
-
Global Artificial Intelligence (Ai) In Epidemiology Market Forecast 2024-2032
... facilitating the market’s growth include the early detection and surveillance of disease outbreaks, the growing need for predictive modeling to forecast disease trends, and data availability for epidemiological research. MARKET INSIGHTS Early detection and surveillance ... Read More
-
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
H3N2 infection - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Personalized Medicine Market Report by Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics, Personalized Medical Care, and Personalized Nutrition and Wellness), Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, and Others), End-Users (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), Region and Company Analysis 2024-2032
... & Academic Institutes, and Others), Region and Company Analysis 2024-2032 The global personalized medicine market was worth US$ 511.09 billion in 2023 and is expected to grow at a CAGR of 7.02% from 2024 to ... Read More
-
Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024
... development scenario and growth prospects across the Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) market. A detailed picture of the Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) pipeline landscape is provided, which includes the disease overview and ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Global Pneumonia Vaccine Market Growth 2024-2030
... Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Pneumonia Vaccine market. Pneumonia Vaccine ... Read More
-
2024 Global Forecast for Microneedle Flu Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Measles, Mumps And Rubella (Mmr) Vaccines Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
RNAi Drug Delivery Market Size, Trends, Analysis, and Outlook By Technology (Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery), By Application (Infectious diseases, Oncology, Cardiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global RNAi Drug Delivery market size is poised to register 17.5% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
Research Assistance
